10-bromo-5-(2-aminoethyl)-2,3,4,7,8,9-hexahydrobenzo[1,2b:4,5b']dipyran | 502659-24-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 10-bromo-5-(2-aminoethyl)-2,3,4,7,8,9-hexahydrobenzo[1,2b:4,5b']dipyran
• 英文别名: 2C-B-Butterfly；2-(5-bromo-2,3,4,7,8,9-hexahydropyrano[2,3-g]chromen-10-yl)ethanamine
• CAS: 502659-24-7
• 化学式: C₁₄H₁₈BrNO₂
• 分子量: 312.206
• InChiKey: PAFZDNLBBBZEKE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  44.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  5-(2-aminoethyl)-2,3,4,7,8,9-hexahydrobenzo[1,2b:4,5b']dipyran hydrochloride 在 溴 、 溶剂黄146 作用下， 反应 4.0h， 生成 10-bromo-5-(2-aminoethyl)-2,3,4,7,8,9-hexahydrobenzo[1,2b:4,5b']dipyran
  参考文献：
  名称：

  Substituted hexahydrobenzodipyrans as 5-HT2A/2C receptor probes

  摘要：

  A pair of substituted hexahydrobenzodipyrans was designed as molecular probes for determining the steric restrictions of the agonist binding site of serotonin 5-HT2A and 5-HT2C receptors. The rationale for the design of these receptor ligands, their chemical synthesis, rat behavioral pharmacology in the two-lever drug discrimination assay using LSD-trained rats, affinity for cloned rat 5-HT2A and 5-HT2c receptors and agonist functional activities are reported. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(02)00209-2

文献信息

• [EN] PHENALKYLAMINES AND METHODS OF TREATING MOOD DISORDERS<br/>[FR] PHÉNALKYLAMINES ET PROCÉDÉS DE TRAITEMENT DE TROUBLES DE L'HUMEUR
  申请人：GILGAMESH PHARMACEUTICALS INC

  公开号：WO2022006186A1

  公开（公告）日：2022-01-06

  Phenalkylamines and methods of treating mood disorders with phenalkylamines. Also provided are pharmaceutical compositions that include phenalkylamines.

  Phenalkylamines和使用Phenalkylamines治疗情绪障碍的方法。还提供了包含Phenalkylamines的制药组合物。
• Substituted hexahydrobenzodipyrans as 5-HT2A/2C receptor probes
  作者：M Whiteside

  DOI：10.1016/s0968-0896(02)00209-2

  日期：2002.10

  A pair of substituted hexahydrobenzodipyrans was designed as molecular probes for determining the steric restrictions of the agonist binding site of serotonin 5-HT2A and 5-HT2C receptors. The rationale for the design of these receptor ligands, their chemical synthesis, rat behavioral pharmacology in the two-lever drug discrimination assay using LSD-trained rats, affinity for cloned rat 5-HT2A and 5-HT2c receptors and agonist functional activities are reported. (C) 2002 Elsevier Science Ltd. All rights reserved.